Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03616535 · ClinicalTrials.gov registry record · NA

Interventions Made to Preserve Cognitive Function

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
130
Enrollment target

NCT03616535: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT03616535 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03616535, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
130 participants
Enrollment target

Study Summary

This is a randomized, controlled trial to slow cognitive decline in adults undergoing hemodialysis (HD). The investigators will test three interventions cognitive training (CT), exercise training (ET), and combined cognitive and exercise training (CT+ET) relative to standard of care (SC).

Primary Outcome

Change in executive function between baseline and 3 months as assessed by the Trail Making Test which is comprised of Part A and Part B. Executive function is assessed by the time (seconds) to complete Part B minus the time (seconds) to complete Part A. Needing more time to complete the test indicates worse executive function.

Interventions

  • OTHER Exercise training
  • OTHER Cognitive training
  • OTHER Combined cognitive and exercise training

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2018-08-30
Est. Completion 2023-09-20
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT03616535 stopped before completion

NCT03616535 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 3 interventions - of which Exercise training is the first listed.

NCT03616535 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03616535 about?

NCT03616535 is a clinical study titled "Interventions Made to Preserve Cognitive Function". This is a randomized, controlled trial to slow cognitive decline in adults undergoing hemodialysis (HD). The investigators will test three interventions cognitive training (CT), exercise training (ET), and combined cognitive and exercise training (CT+ET) relative to standard of care (SC).

What is the current status of trial NCT03616535?

This trial is currently terminated. It is a NA study. The enrollment target is 130 participants. The study started on 2018-08-30. Estimated completion is 2023-09-20.

What interventions are being tested in trial NCT03616535?

The interventions under investigation include: Exercise training (OTHER), Cognitive training (OTHER), Combined cognitive and exercise training (OTHER).

Who is sponsoring clinical trial NCT03616535?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03616535's enrollment target sits among peer trials

130 733rd of 2000 higher than 1,257 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03616535, the US trial registry maintained by the National Library of Medicine. NCT03616535 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.